Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prime Ranchers was a Ugandan cannabis cultivation and extraction company operating as Prime Ranchers Limited. The company was used by EXMceuticals as its local subsidiary/joint-venture vehicle in Uganda to cultivate cannabis, extract cannabinoids, and export pharmaceutical-, therapeutic-, nutraceutical-, and cosmetic-grade cannabis ingredients. Public sources indicate the business was licensed in Uganda in 2019 and was positioned around large-scale industrial cultivation and processing rather than development of a proprietary drug pipeline. Later sources indicate the company was acquired in November 2018 by EXMceuticals and that EXMceuticals subsequently agreed to sell a 70% stake in 2020. Based on the available evidence, Prime Ranchers appears to have been an operating cannabis ingredients business rather than a traditional biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prime Ranchers.